|
Volumn 278, Issue 9, 2003, Pages 6936-6941
|
Characterization of a novel negative regulator (DOC-2/DAB2) of c-Src in normal prostatic epithelium and cancer
|
Author keywords
[No Author keywords available]
|
Indexed keywords
AMINO ACIDS;
CELLS;
ENZYMES;
TUMORS;
PHOSPHORYLATION;
BIOCHEMISTRY;
DIFFERENTIALLY EXPRESSED IN OVARIAN CARCINOMA 2 PROTEIN;
DISABLED 2 PROTEIN;
GROWTH FACTOR;
MITOGEN ACTIVATED PROTEIN KINASE;
PROTEIN KINASE C;
RAS PROTEIN;
REGULATOR PROTEIN;
TYROSINE;
UNCLASSIFIED DRUG;
DAB2 PROTEIN, HUMAN;
ENZYME INHIBITOR;
GLUTATHIONE TRANSFERASE;
HYBRID PROTEIN;
PEPTIDE;
PROTEIN TYROSINE KINASE;
PROTEIN TYROSINE KINASE C SRC;
PROTEIN-TYROSINE KINASE C-SRC;
SIGNAL TRANSDUCING ADAPTOR PROTEIN;
VESICULAR TRANSPORT ADAPTOR PROTEIN;
ANIMAL CELL;
ARTICLE;
CANCER GROWTH;
CONTROLLED STUDY;
GENE EXPRESSION;
HUMAN;
HUMAN CELL;
NONHUMAN;
ONCOGENE SRC;
PRIORITY JOURNAL;
PROSTATE CANCER;
PROSTATE EPITHELIUM;
PROTEIN BINDING;
PROTEIN DOMAIN;
PROTEIN INTERACTION;
PROTEIN PHOSPHORYLATION;
TUMOR SUPPRESSOR GENE;
ANIMAL;
BIOLOGICAL MODEL;
CELL CULTURE;
CELL STRAIN COS1;
CHEMISTRY;
DRUG ANTAGONISM;
ENZYME ACTIVATION;
GENETIC TRANSFECTION;
MALE;
METABOLISM;
MUTATION;
PHOSPHORYLATION;
PROSTATE;
PROSTATE TUMOR;
PROTEIN CONFORMATION;
PROTEIN SYNTHESIS;
PROTEIN TERTIARY STRUCTURE;
SERODIAGNOSIS;
SIGNAL TRANSDUCTION;
TIME;
ANIMALIA;
ADAPTOR PROTEINS, SIGNAL TRANSDUCING;
ADAPTOR PROTEINS, VESICULAR TRANSPORT;
ANIMALS;
COS CELLS;
ENZYME ACTIVATION;
ENZYME INHIBITORS;
GENES, TUMOR SUPPRESSOR;
GLUTATHIONE TRANSFERASE;
HUMANS;
MALE;
MITOGEN-ACTIVATED PROTEIN KINASES;
MODELS, BIOLOGICAL;
MUTATION;
PEPTIDES;
PHOSPHORYLATION;
PRECIPITIN TESTS;
PROSTATE;
PROSTATIC NEOPLASMS;
PROTEIN BINDING;
PROTEIN BIOSYNTHESIS;
PROTEIN CONFORMATION;
PROTEIN KINASE C;
PROTEIN STRUCTURE, TERTIARY;
PROTEIN-TYROSINE KINASES;
RECOMBINANT FUSION PROTEINS;
SIGNAL TRANSDUCTION;
TIME FACTORS;
TRANSFECTION;
TUMOR CELLS, CULTURED;
TYROSINE;
|
EID: 0037470132
PISSN: 00219258
EISSN: None
Source Type: Journal
DOI: 10.1074/jbc.M210628200 Document Type: Article |
Times cited : (61)
|
References (30)
|